BioSpace News Archive

Vivacitas Oncology, Inc. , a clinical stage biopharmaceutical company focused on tough to treat cancers, and Image Analysis Group a leading global medical imaging company, are collaborating to apply Artificial Intelligence (AI) technology and advanced imaging strategies to further the development of AR-67, a third generation Camptothecin, in patients with recurrent glioblastoma multiforme

Escient Pharmaceuticals, Inc., a clinical-stage, industry-leading platform company developing Mas-related G Protein-Coupled Receptor (MRGPR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications, today announced the appointment of Svetlana Makhni as Chief Financial Officer effective May 3, 2021

The partnership with Fluence expands Tryp’s ability to conduct comprehensive clinical trials and leverage invaluable experience and insight from the leader in psychedelic therapy training

- Dr. Morich is an industry leader with over 35 years of experience in biopharmaceuticals with focus in commercialization, R&D and product development - - Previously served as Chief Commercial Officer of Takeda Pharmaceutical Company, Chief Executive Officer of Takeda Pharmaceutical International, Chief Executive Officer of NOXXON Pharma AG, Chief Executive Officer of Innogenetics N.V., and Head of Global Product Development of Bayer AG Pharmaceutical Division -

St. Elizabeth’s Medical Center announced a new academic and clinical affiliation with the Boston University School of Medicine that will bring enhanced, innovative medical education and clinical research opportunities to Steward Health Care’s flagship tertiary care facility.

Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural killer (NK) and Macrophage cellular immunotherapies derived from induced pluripotent stem cells (iPSC) for cancer and other serious diseases, today announced the appointment of Vanessa L. Jacoby as Chief Financial Officer.

NuProbe Global, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing assays, announced research demonstrating the ability to detect single nucleotide variants (SNVs) in DNA with a variant allele frequency (VAF) of ≤0.02% using a sequencing depth of only 250x.

AditxtScore™ Center is the first of a planned immune monitoring network and will initially monitor COVID-19 immunity status New facility expects to target more than 300 jobs over three years to the area

The Nagourney Cancer Institute announced that as part of its efforts to advance the understanding of human metabolism and the pivotal role that it plays in cancer, it will benefit from the Rosalie and Harold Rae Brown Foundation’s $2 million gift to The Vanguard Cancer Foundation.

Pharmazz, Inc., a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care.